185 related articles for article (PubMed ID: 23915136)
1. Thyroid hormone analogues: where do we stand in 2013?
Meruvu S; Ayers SD; Winnier G; Webb P
Thyroid; 2013 Nov; 23(11):1333-44. PubMed ID: 23915136
[TBL] [Abstract][Full Text] [Related]
2. Thyroid hormone receptor and lipid regulation.
Webb P
Curr Opin Investig Drugs; 2010 Oct; 11(10):1135-42. PubMed ID: 20872316
[TBL] [Abstract][Full Text] [Related]
3. Thyroid Hormone Analogues: An Update.
Zucchi R
Thyroid; 2020 Aug; 30(8):1099-1105. PubMed ID: 32098589
[TBL] [Abstract][Full Text] [Related]
4. Cross-talk between the thyroid and liver: a new target for nonalcoholic fatty liver disease treatment.
Huang YY; Gusdon AM; Qu S
World J Gastroenterol; 2013 Dec; 19(45):8238-46. PubMed ID: 24363514
[TBL] [Abstract][Full Text] [Related]
5. Thyromimetics: a journey from bench to bed-side.
Tancevski I; Rudling M; Eller P
Pharmacol Ther; 2011 Jul; 131(1):33-9. PubMed ID: 21504761
[TBL] [Abstract][Full Text] [Related]
6. New insights into thyroid hormone action.
Oetting A; Yen PM
Best Pract Res Clin Endocrinol Metab; 2007 Jun; 21(2):193-208. PubMed ID: 17574003
[TBL] [Abstract][Full Text] [Related]
7. Metabolic effects of thyroid hormone derivatives.
Moreno M; de Lange P; Lombardi A; Silvestri E; Lanni A; Goglia F
Thyroid; 2008 Feb; 18(2):239-53. PubMed ID: 18279024
[TBL] [Abstract][Full Text] [Related]
8. Role of thyroid receptor β in lipid metabolism.
Pramfalk C; Pedrelli M; Parini P
Biochim Biophys Acta; 2011 Aug; 1812(8):929-37. PubMed ID: 21194564
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in thyroid research: selective thyroid hormone receptor modulators (STRMs).
Kraiem Z
Pediatr Endocrinol Rev; 2003 Dec; 1 Suppl 2():257-60; discussion 260. PubMed ID: 16444167
[TBL] [Abstract][Full Text] [Related]
10. Thyroid hormones and thyroid hormone receptors: effects of thyromimetics on reverse cholesterol transport.
Pedrelli M; Pramfalk C; Parini P
World J Gastroenterol; 2010 Dec; 16(47):5958-64. PubMed ID: 21157972
[TBL] [Abstract][Full Text] [Related]
11. Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders.
Saponaro F; Sestito S; Runfola M; Rapposelli S; Chiellini G
Front Med (Lausanne); 2020; 7():331. PubMed ID: 32733906
[TBL] [Abstract][Full Text] [Related]
12. Development of Thyroid Hormones and Synthetic Thyromimetics in Non-Alcoholic Fatty Liver Disease.
Zhao M; Xie H; Shan H; Zheng Z; Li G; Li M; Hong L
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163026
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic Fatty Liver Disease and Hypercholesterolemia: Roles of Thyroid Hormones, Metabolites, and Agonists.
Sinha RA; Bruinstroop E; Singh BK; Yen PM
Thyroid; 2019 Sep; 29(9):1173-1191. PubMed ID: 31389309
[No Abstract] [Full Text] [Related]
14. Potential Role of Thyroid Receptor β Agonists in the Treatment of Hyperlipidemia.
Jakobsson T; Vedin LL; Parini P
Drugs; 2017 Oct; 77(15):1613-1621. PubMed ID: 28865063
[TBL] [Abstract][Full Text] [Related]
15. Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index.
Erion MD; Cable EE; Ito BR; Jiang H; Fujitaki JM; Finn PD; Zhang BH; Hou J; Boyer SH; van Poelje PD; Linemeyer DL
Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15490-5. PubMed ID: 17878314
[TBL] [Abstract][Full Text] [Related]
16. Thyroid receptor ligands. 1. Agonist ligands selective for the thyroid receptor beta1.
Ye L; Li YL; Mellström K; Mellin C; Bladh LG; Koehler K; Garg N; Garcia Collazo AM; Litten C; Husman B; Persson K; Ljunggren J; Grover G; Sleph PG; George R; Malm J
J Med Chem; 2003 Apr; 46(9):1580-8. PubMed ID: 12699376
[TBL] [Abstract][Full Text] [Related]
17. Lipid lowering with thyroid hormone and thyromimetics.
Angelin B; Rudling M
Curr Opin Lipidol; 2010 Dec; 21(6):499-506. PubMed ID: 20935564
[TBL] [Abstract][Full Text] [Related]
18. Selective agonists and antagonists to thyroid hormone action.
Kraiem Z
Thyroid; 2005 Apr; 15(4):336-9. PubMed ID: 15876155
[TBL] [Abstract][Full Text] [Related]
19. Thyroid hormone analogs for the treatment of dyslipidemia: past, present, and future.
Delitala AP; Delitala G; Sioni P; Fanciulli G
Curr Med Res Opin; 2017 Nov; 33(11):1985-1993. PubMed ID: 28498022
[TBL] [Abstract][Full Text] [Related]
20. Thyroid hormones as a disease modifier and therapeutic target in nonalcoholic steatohepatitis.
Wirth EK; Puengel T; Spranger J; Tacke F
Expert Rev Endocrinol Metab; 2022 Sep; 17(5):425-434. PubMed ID: 35957531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
